98 research outputs found

    Improving Physician Office Quality Measures by Evaluating Statin Prescribing in Type 2 Diabetic Patients

    Get PDF
    Abstract Objective The focus of this study was to evaluate the impact of pharmacist’ intervention on quality metrics focusing on patients with a diagnosis of diabetes mellitus type II (T2DM) not currently prescribed statin therapy. Methods This retrospective cohort investigational study was conducted in four lowest performing office locations of a nineteen regional primary care physician group practice. Inclusion criteria were diagnosis of T2DM without active statin therapy. Data was excluded from analysis for patients younger than age 40 or older than age 75, or if the most recent LDL documented was less than 70 mg/dL. Recommendations for initiation of statin therapy were sent electronically to the patient’s primary care physician via EMR software. Results Preliminary screening in March 2018 demonstrated a total of 2206 patients diagnosed with T2DM, for which 790 patients were not actively prescribed statin therapy. 468 patients were identified as eligible for statin therapy. Endpoint analysis in November 2018 showed that of the initial 468 patients who were eligible for a statin, 74 had been prescribed a statin, and 23 patients fell out of study criteria. Implications The efficacy of statin interventions is supported by the practice entity’s improvement in STAR ratings for the Medicare Advantage populations, in which two major payer groups saw increases in statin use in diabetes measures. Standard of care combined with pharmacist-led interventions correlated to a 4-STAR rating for the practice entity as of October 2018. Pharmacists can play an important role in helping physicians meet these quality metrics

    Absorption Characteristics and Quantum Yields of Singlet Oxygen Generation of Thioguanosine Derivatives

    Get PDF
    6–Thioguanine (1a) is considered to be photochemotherapeutic agents due to its specific characteristics of photosensitivity to UVA light and singlet molecular oxygen generation. To extend its phototherapeutic ability, two related thioguanines, 8–thioguanine (2a) and 6,8–dithioguanine (3a), have been designed and explored. Since the solubility of these thioguanines in dehydrated organic solvents is too poor to study, their tri–acetyl–protected ribonucleosides, i.e. 2’,3’,5’–tri–O–acetyl–6–thioguanosine (1c), 2’,3’,5’–tri–O–acetyl–8–thioguanosine (2c) and 2’,3’,5’–tri–O–acetyl–6,8–dithioguanosine (3c) were prepared and investigated. The absorption maxima of 1c, 2c and 3c in acetonitrile were found at longer wavelengths than that of un–thiolated guanosine (4c). Especially, 3c has the longest wavelength for absorption maximum and the highest value in terms of molar absorption coefficient among all thio–nucleobases and thio–nucleosides reported. These absorption properties were also well reproduced by quantum chemical calculations. Quantum yields of singlet oxygen generation of 2c and 3c were determined by near–infrared emission measurements to be as large as that of 1c. These results suggest that the newly synthesized thioguanosines, in particular 3c, can be further developed as a potential photosensitive agent for light–induced therapies

    THEO 264-81 Synoptic Gospels

    No full text
    • …
    corecore